Intrathecal human tetanus immunoglobulin in early tetanus.
97 patients with symptoms of early tetanus at the time of admission to hospital were treated with sedation, antibiotics, and human tetanus immune globulin (TIG). After intrathecal TIG 250 IU 3 patients out of 49 got worse but only 1 died while in a closely similar group of 48 patients in whom TIG was administered intramuscularly in dose of 1000 IU, the clinical features of the disease became severer in 15 (31%) and 10 (21%) died. The intrathecal use of TIG was devoid of side effects.
D000293:Adolescent; D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage; D007278:Injections, Spinal; D008297:Male; D008875:Middle Aged; D013742:Tetanus / Q000628:therapy*; D013743:Tetanus Antitoxin / Q000008:administration & dosage*; D013997:Time Factors
D007136:Immunoglobulins; D013743:Tetanus Antitoxin